Atlas Trials

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis

Clinical trial NCT07749768 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07749768
Sponsor
Ono Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Ulcerative Colitis (UC)
Start date
2026-09-30
Primary completion
2027-12-31
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.